SCHEMBL1006355

SCHEMBL1006355

Cc1ccc2oc(N3CCOCC3C(C)C)nc2c1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 11/20 0.52
KCNH2 Q12809 2/20 0.34
AURKA O14965 1/20 0.33
PDPK1 O15530 1/20 0.33
ROCK1 Q13464 1/20 0.33
AURKB Q96GD4 1/20 0.33
PIK3CD O00329 1/20 0.32
IDH1 O75874 2/20 0.32
FKBP1A P62942 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PIK3C3 Q8NEB9 1/20 0.31
NR1H2 P55055 1/20 0.30
NR1H3 Q13133 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1006356 1.00 HTR3A (0.52) HTR3AKCNH2AURKAPDPK1ROCK1
SCHEMBL1006363 1.00 HTR3A (0.52) HTR3AKCNH2AURKAPDPK1ROCK1
SCHEMBL1005781 0.86 HTR3A (0.49) HTR3A
SCHEMBL1006741 0.86 HTR3A (0.49) HTR3A
SCHEMBL1005780 0.86 HTR3A (0.49) HTR3A
SCHEMBL3984271 0.86 HTR3A (0.53) HTR3AKCNH2FKBP1AALDH1A1L3MBTL1
SCHEMBL1006857 0.86 HTR3A (0.53) HTR3AKCNH2FKBP1AALDH1A1L3MBTL1
SCHEMBL1004321 0.84 HTR3A (0.51) HTR3AKCNH2AURKAPDPK1
SCHEMBL1005156 0.84 HTR3A (0.51) HTR3AKCNH2AURKAPDPK1
SCHEMBL1004322 0.84 HTR3A (0.51) HTR3AKCNH2AURKAPDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863271-B2 2-aminobenzoxazole carboxamides as 5HT3 modulators ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
EP-2061460-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS Albany Molecular Research, Inc. (US) 2009-05-27 EP disclosed
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS AMR TECHNOLOGY, INC. (US) 2008-10-16 US disclosed
WO-2008019372-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS ALBANY MOLECULAR RESEARCH, INC. (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS HTR3E, HTR3C, HTR3A HTR3A 3/4885KCNH2 1871/4885AURKA 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.